Abstract

Rheumatoid arthritis (RA) flare is related to increased joint damage, disability, and healthcare use. The impact of short-term air pollution exposure on RA disease activity is still a matter of debate. In this cross-sectional study, we investigated whether short-term exposure to particulate matter (PM)10, PM2.5, nitrogen dioxide (NO2), and ozone (O3) affected RA disease activity (DAS28 and SDAI) in 422 consecutive RA residents in Lombardy, North of Italy. Air pollutant concentrations, estimated by Regional Environmental Protection Agency (Lombardy—Italy) at the municipality level, were used to assign short-term exposure from the day of enrolment, back to seven days. Some significant negative associations emerged between RA disease activity, PM10, and NO2, whereas some positive associations were observed for O3. Patients were also stratified according to their ongoing Disease-Modifying anti-Rheumatic Drugs (DMARDs) treatment: no DMARDs (n = 25), conventional synthetic DMARDs (n = 108), and biological or targeted synthetic DMARDs (n = 289). Therapy interaction seemed partially able to influence the relationship between short-term air pollution exposure and RA disease activity (PM2.5 levels and DAS28 at the day of the visit-O3 levels and disease activity scores for the seven days before the evaluation). According to our results, the impact of short-term air pollution exposure (seven days) minimally impacts disease activity. Moreover, our study suggests therapy could alter the response to environmental factors. Further evidence is needed to elucidate determinants of RA flare and its management.

Highlights

  • Rheumatoid arthritis (RA) is an autoimmune disease and it is mainly characterized by inflammatory joint involvement, potentially leading to progressive disability

  • A total of 422 consecutive RA patients were enrolled with a mean age of 58.2 years and a mean disease duration of 16.1 years

  • RA patients were stratified into three subgroups according to ongoing treatment: 25 subjects were without ongoing Disease-Modifying anti-Rheumatic Drugs (DMARDs); 108 subjects were treated with csDMARDs, and 289 patients were treated with b/tsDMARDs

Read more

Summary

Introduction

Rheumatoid arthritis (RA) is an autoimmune disease and it is mainly characterized by inflammatory joint involvement, potentially leading to progressive disability. RA is considered a global public health challenge with almost 20 million prevalent cases, 1.2 million incident cases, and 3.4 million disability-adjusted life years [1]. Despite considerable advances in RA pathogenesis, both genetic and environmental factors have not been fully clarified. Environmental exposures, such as cigarette smoking, silica dust, and mineral oil, can promote oxidative stress, increase inflammation, and induce bronchus-associated lymphoid tissue to produce anti-citrullinated protein antibodies (ACPA) [2,3,4,5,6]. In a meta-analysis published in 2020, long-term exposure to ozone (O3 ) and living near traffic roads were reported to

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call